Search Results - "BALAN, Vijayan"

Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized Study of Treatment duration and ribavirin dose by HADZIYANNIS, Stephanos J, SETTE, Hoel JR, ZEUZEM, Stefan, POCKROS, Paul J, LIN, Amy, ACKRILL, Andrew M, MORGAN, Timothy R, VIJAYAN BALAN, DIAGO, Moises, MARCELLIN, Patrick, RAMADORI, Giuliano, BODENHEIMER, Henry JR, BERNSTEIN, David, RIZZETTO, Mario

Get full text

Recurrence of autoimmune liver disease after liver transplantation: A systematic review by Gautam, Manjushree, Cheruvattath, Rekha, Balan, Vijayan

Get full text

Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy by Pasha, Shabana F., MD, Harrison, M. Edwyn, MD, Das, Ananya, MD, Nguyen, Cuong C., MD, Vargas, Hugo E., MD, Balan, Vijayan, MD, Byrne, Thomas J., MD, Douglas, David D., MD, Mulligan, David C., MD

“…Background The optimal endoscopic treatment for anastomotic biliary strictures after deceased donor liver transplantation is undefined. Endoscopic therapy with…”
Get full text

Long‐term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database by Balan, Vijayan, Ruppert, Kris, Demetris, A. Jake, Ledneva, Tatiana, Duquesnoy, Rene J., Detre, Katherine M., Wei, Yuling L., Rakela, Jorge, Schafer, Daniel F., Roberts, John P., Everhart, James E., Wiesner, Russell H.

“…A perfect or nearly perfect human leukocyte antigen (HLA) match has been associated with better immediate and long‐term survival of diseased donor kidney…”
Get full text

Liver transplantation for hepatocellular carcinoma: The MELD impact by Sharma, Pratima, Balan, Vijayan, Hernandez, Jose L., Harper, Ann M., Edwards, Erick B., Rodriguez‐Luna, Hector, Byrne, Thomas, Vargas, Hugo E., Mulligan, David, Rakela, Jorge, Wiesner, Russell H.

“…The new allocation policy of the United Network of Organ Sharing (UNOS) based on the model for end‐stage liver disease (MELD) gives candidates with stage T1 or…”
Get full text

Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon Ribavirin by BALAN, Vijayan, SCHWARTZ, David, BOWERS, Peter J, LEITZ, Gerhard J, WU, George Y, MUIR, Andrew J, GHALIB, Reem, JACKSON, John, KEEFFE, Emmet B, ROSSARO, Lorenzo, BURNETT, Alfreda, GOON, Betty L

“…In hepatitis C virus (HCV)-infected patients receiving pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy, anemia is a well-known side effect…”
Get full text

Outcome of liver transplantation for familial amyloidotic polyneuropathy by Sharma, Pratima, Perri, Roman E., Sirven, Joseph E., Zeldenrust, Steven R., Brandhagen, David J., Rosen, Charles B., Douglas, David D., Mulligan, David C., Rakela, Jorge, Wiesner, Russell H., Balan, Vijayan

“…Familial amyloidotic polyneuropathy (FAP) is an amosomal dominant disorder caused by mutation in the transthyretin gene. The most common mutation is…”
Get full text

Acute hepatitis E by a new isolate acquired in the United States by Kwo, P Y, Schlauder, G G, Carpenter, H A, Murphy, P J, Rosenblatt, J E, Dawson, G J, Mast, E E, Krawczynski, K, Balan, V

“…To report the first case of acute hepatitis E by a novel isolate acquired in the United States and confirmed by nucleotide sequencing. We describe the clinical…”
Get more information

Changes in B-lymphocyte stimulator protein levels during treatment with albinterferon alfa-2b in patients with chronic hepatitis C who have failed previous interferon therapy by Rustgi, Vinod, Nelson, David R., Balan, Vijayan, Abelson, Robert D., Fiscella, Michele, Migone, Thi-Sau, Pulkstenis, Erik, Subramanian, G. Mani

“…Aim:  The pharmacodynamics of albinterferon alfa‐2b (alb‐IFN), a novel recombinant protein consisting of interferon‐α‐2b genetically fused to human albumin,…”
Get full text

Recurrence of autoimmune liver disease after liver transplantation: A systematic review by Gautam, Manjushree, Cheruvattath, Rekha, Balan, Vijayan

“…Recurrence of autoimmune liver disease in allografts has long been a topic of debate. We conducted a systematic review of the literature to examine the…”
Get full text

Infections in Patients With End-stage Liver Disease by Cheruvattath, Rekha, Balan, Vijayan

“…Infections in patients with end-stage liver disease (ESLD) are an important cause of morbidity and mortality in these patients. Abnormalities in their natural…”
Get full text

Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation by Balan, V, Batts, K P, Porayko, M K, Krom, R A, Ludwig, J, Wiesner, R H

“…Whether primary biliary cirrhosis recurs after orthotopic liver transplantation remains a controversial issue. Sixty consecutive patients with primary biliary…”
Get more information

In a 12-Year Study, Sustainability of Quality of Life Benefits After Liver Transplantation Varies With Pretransplantation Diagnosis by Ruppert, Kristine, Kuo, Shihchen, DiMartini, Andrea, Balan, Vijayan

“…Background & Aims As life-extending benefits of liver transplantation (LTX) are realized, the focus of improving outcomes after LTX transitioned from merely…”
Get full text

Rat Hepatocytes Transport Water Mainly via a Non-channel-mediated Pathway by Yano, M, Marinelli, R A, Roberts, S K, Balan, V, Pham, L, Tarara, J E, de Groen, P C, LaRusso, N F

“…During bile formation by the liver, large volumes of water are transported across two epithelial barriers consisting of hepatocytes and cholangiocytes ( i.e…”
Get full text

Perplexing Lesions of the Sinonasal Cavity and Skull Base: IgG4-related and Similar Inflammatory Diseases by Cain, Rachel B., Colby, Thomas V., Balan, Vijayan, Patel, Naresh P., Lal, Devyani

“…Objective IgG4-related disease (IgG4RD) causing sinonasal and skull base pathology is uncommonly described. We present a series of suspected IgG4RD patients,…”
Get full text

Hepatobiliary disease in inflammatory bowel disease by Balan, V, LaRusso, N F

“…PSC is the most common and most important hepatobiliary disease seen in association with IBD. Approximately 5% of all patients with CUC have PSC, and most…”
Get more information

Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on liver transplantation and hepatitis C by Wiesner, Russell H., Sorrell, Michael, Villamil, Federico, International Liver Transplantation Society Expert Panel

Get full text

Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon α2b and ribavirin: An open-label series by RODRIGUEZ-LUNA, Hector, KHATIB, Amer, BALAN, Vijayan, RAKELA, Jorge, VARGAS, Hugo E, SHARMA, Pratima, DE PETRIS, Giovanni, WILLIAMS, James W, ORTIZ, Jose, HANSEN, Kathleen, MULLIGAN, David, MOSS, Adyr, DOUGLAS, David D

Get full text

1007-LBP: A Novel Measure of Recipient-Donor HLA Mismatch Predicts Allograft Rejection After Heart Transplantation by Kransdorf, Evan P., Carvajal, Tomas, Steidley, D. Eric, Balan, Vijayan, Bordner, Andrew, Pajaro, Octavio E.

“…It has previously been shown that human leukocyte antigen mismatch (HLAMM) between a transplant recipient and donor at the level of allele groups (previously…”
Get full text

Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation by Corey, Rebecca L., Whitaker, Michael D., Crowell, Michael D., Keddis, Mira T., Aqel, Bashar, Balan, Vijayan, Byrne, Thomas, Carey, Elizabeth, Douglas, David D., Harrison, M. Edwyn, Vargas, Hugo E., Rakela, Jorge

“…Vitamin D deficiency is common among patients with end‐stage liver disease (ESLD). The primary aim of our study was to assess the prevalence of vitamin D…”
Get full text